Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer’s Disease and Geriatric Depression

por Savonije, Karl, Meek, Autumn, Weaver, Donald F.
Publicado 2023

Is Inhaled Furosemide a Potential Therapeutic for COVID-19?

por Brennecke, Anja, Villar, Laura, Wang, Zhiyu, Doyle, Lisa M., Meek, Autumn, Reed, Mark, Barden, Christopher, Weaver, Donald F.
Publicado 2020

Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide

por Wang, Zhiyu, Wang, Yanfei, Vilekar, Prachi, Yang, Seung-Pil, Gupta, Mayuri, Oh, Myong In, Meek, Autumn, Doyle, Lisa, Villar, Laura, Brennecke, Anja, Liyanage, Imindu, Reed, Mark, Barden, Christopher, Weaver, Donald F.
Publicado 2020

Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites

por Meier‐Stephenson, Felix S., Meier‐Stephenson, Vanessa C., Carter, Michael D., Meek, Autumn R., Wang, Yanfei, Pan, Luzhe, Chen, Qiangwei, Jacobo, Sheila, Wu, Fan, Lu, Erhu, Simms, Gordon A., Fisher, Laural, McGrath, Alaina J., Fermo, Virgil, Barden, Christopher J., Clair, Harman D.S., Galloway, Todd N., Yadav, Arun, Campágna‐Slater, Valérie, Hadden, Mark, Reed, Mark, Taylor, Marcia, Kelly, Brendan, Diez‐Cecilia, Elena, Kolaj, Igri, Santos, Clarissa, Liyanage, Imindu, Sweeting, Braden, Stafford, Paul, Boudreau, Robert, Reid, G. Andrew, Noyce, Ryan S., Stevens, Leanne, Staniszewski, Agnieszka, Zhang, Hong, Murty, Mamidanna R. V. S., Lemaire, Pascale, Chardonnet, Solenne, Richardson, Christopher D., Gabelica, Valérie, DePauw, Edwin, Brown, Richard, Darvesh, Sultan, Arancio, Ottavio, Weaver, Donald F.
Publicado 2022